Improving attention to reduce social anxiety in young people
Targeting Attention Orienting to Social Threat to Reduce Social Anxiety in Youth
This study is testing a new treatment called attention bias modification treatment (ABMT) to help kids aged 10 to 14 who have social anxiety by teaching them to focus less on scary social situations, which could make them feel less anxious and help them interact better with others.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida International University NIH-funded |
| Lab location | 1 site (Miami, United States) |
| Project ID | NIH-10595000 on NIH RePORTER |
What this research studies
This research focuses on a treatment called attention bias modification treatment (ABMT) aimed at helping youth aged 10 to 14 who struggle with social anxiety disorder (SAD). The study will explore how ABMT can effectively change the way these young individuals focus their attention, particularly towards social threats, which may help alleviate their anxiety symptoms. By using advanced cognitive neuroscience techniques, the researchers will assess the treatment's effectiveness and the underlying mechanisms that contribute to its success. Participants will engage in activities designed to modify their attention patterns, potentially leading to improved social interactions and reduced anxiety.
Who could benefit from this research
Good fit: Ideal candidates for this research are youth aged 10 to 14 who have been diagnosed with social anxiety disorder.
Not a fit: Patients outside the age range of 10 to 14 or those without social anxiety disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective treatment option for young people suffering from social anxiety disorder.
How similar studies have performed: Previous research has shown promise for attention bias modification techniques in treating anxiety disorders, suggesting potential for success in this approach.
Where this research is happening
Miami, United States
- Florida International University — Miami, United States (Active)
Researchers
- Principal investigator: Pettit, Jeremy W — Florida International University
- Study coordinator: Pettit, Jeremy W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.